This is a demo store. No orders will be fulfilled.

Elimusertib hydrochloride - 98%, high purity , CAS No.1876467-74-1(free base)

In stock
Item Number
E414104
Grouped product items
SKU Size
Availability
Price Qty
E414104-2mg
2mg
2
$181.90
E414104-5mg
5mg
2
$343.90
E414104-10mg
10mg
2
$583.90
E414104-25mg
25mg
2
$1,029.90
E414104-50mg
50mg
2
$1,716.90
E414104-100mg
100mg
2
$2,952.90

ATR Selective Inhibitors

View related series
DNA Damage (697)

Basic Description

Synonyms BAY 1895344 hydrochloride | BAY-1895344 HCl | 2-​[(3R)​-​3-​methyl-​4-​morpholinyl]​-​4-​(1-​methyl-​1H-​pyrazol-​5-​yl)​-​8-​(1H-​pyrazol-​3-​yl)​-1,​7-​Naphthyridine hydrochloride
Specifications & Purity Moligand™, ≥98%
Biochemical and Physiological Mechanisms Elimusertib (BAY-1895344) hydrochloride is a potent, highly selective and orally available ATR inhibitor with an IC50 of 7 nM.
Storage Temp Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Grade Moligand™
Product Description

Information

Elimusertib (BAY-1895344) hydrochloride is a potent, highly selective and orally availableATRinhibitor with an IC50 of 7 nM.


Targets

ATR (Cell-free assay) 7 nM


In vitro

BAY 1895344 is shown to be a very potent and highly selective ATR inhibitor (IC50 = 7 nM), which potently inhibits proliferation of a broad spectrum of human tumor cell lines (median IC50 = 78 nM). In cellular mechanistic assays BAY 1895344 potently inhibits hydroxyurea-induced H2AX phosphorylation (IC50 = 36 nM).


In vivo

BAY 1895344 reveals significantly improved aqueous solubility, bioavailability across species and no activity in the hERG patch-clamp assay. It also demonstrates very promising efficacy in monotherapy in DNA damage deficient tumor models as well as combination treatment with DNA damage inducing therapies. BAY 1895344 exhibits strong in vivo anti-tumor efficacy in monotherapy in a variety of xenograft models of different indications that are characterized by DDR deficiencies, inducing stable disease in ovarian and colorectal cancer or even complete tumor remission in mantle cell lymphoma models.

Associated Targets(Human)

ATR Tchem Serine/threonine-protein kinase ATR (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
MTOR Tclin Serine/threonine-protein kinase mTOR (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

7 results found

Lot Number Certificate Type Date Item
F2524409 Certificate of Analysis Jun 26, 2025 E414104
K2229688 Certificate of Analysis Oct 19, 2022 E414104
K2229741 Certificate of Analysis Oct 19, 2022 E414104
K2229742 Certificate of Analysis Oct 19, 2022 E414104
K2229747 Certificate of Analysis Oct 19, 2022 E414104
K2229745 Certificate of Analysis Oct 19, 2022 E414104
K2229640 Certificate of Analysis Oct 19, 2022 E414104

Chemical and Physical Properties

Solubility Solubility (25°C) In vitro DMSO: 82 mg/mL (199.08 mM); Water: 82 mg/mL (199.08 mM); Ethanol: 82 mg/mL (199.08 mM);
Sensitivity Moisture sensitive

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.